dithionitrobenzoic acid has been researched along with Chronic Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Ari, Y; Bernard, CL; Esclapez, M; Gozlan, H; Hirsch, JC; Quesada, O | 1 |
1 other study(ies) available for dithionitrobenzoic acid and Chronic Disease
| Article | Year |
|---|---|
Enhanced NMDAR-dependent epileptiform activity is controlled by oxidizing agents in a chronic model of temporal lobe epilepsy.
Topics: Animals; Chronic Disease; Disease Models, Animal; Dithionitrobenzoic Acid; Electric Stimulation; Epilepsy, Temporal Lobe; Evoked Potentials; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; In Vitro Techniques; Kainic Acid; Male; Oxidants; Oxidation-Reduction; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 1996 |